Microbot Medical announces peer reviewed abstracts accepted b CIRSE

Microbot Medical is encouraged by the continued participation and level of enthusiasm being demonstrated by the Key Opinion Leaders globally who are using the LIBERTY Robotic Surgical System during the Company’s pre-clinical animal studies. Further displaying their positive experiences and satisfaction, the Company has been informed that two peer-reviewed abstracts have been accepted to be presented at the Annual Congress of the Cardiovascular and Interventional Radiological Society of Europe, CIRSE. In addition, one of the abstracts was accepted as an oral presentation. “Our goal is to increase awareness amongst leading KOLs to LIBERTY while we establish the necessary data for our regulatory process, primarily for the FDA. We believe that the current and future peer-reviewed data will accelerate adoption of LIBERTY once commercialized,” said Dr. Eyal Morag, Chief Medical Officer of Microbot Medical. “The physician’s desire to take part in our studies and submit a peer-review abstract, as well as accepted by one of the biggest interventional radiology societies, is a testimony of our disruptive solution.”